Ellen Kapiteijn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ellen Kapiteijn

Showing results (11-20 of 158) with videos related to

Pageof 16

Sort By:

Drugs & Aging|July 19, 2019

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with CancerYara van Holstein, Ellen Kapiteijn, Esther Bastiaannet, et al.

Acta Ophthalmologica|July 24, 2025

Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomasMaria Chiara Gelmi, Gulçin Gezgin, Ellen Kapiteijn, et al.

Applied Health Economics and Health Policy|July 17, 2022

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive CancersRenée E Michels, Carlos H Arteaga, Michel L Peters, et al.

European Journal of Endocrinology|May 28, 2020

Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decadesMischa de Ridder, Els Nieveen van Dijkum, Anton Engelsman, et al.

The British Journal of Surgery|August 12, 2025

Management of liver metastases from uveal melanomaAnne Huibers, Andrew Wong, Mark Burgmans, et al.

Cardiovascular and Interventional Radiology|January 1, 2016

Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver MalignanciesMark C Burgmans, Eleonora M de Leede, Christian H Martini, et al.

Cancers|August 25, 2019

Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell CancerMehtap Derya Aydemirli, Willem Corver, Ruben Beuk, et al.

Endocrine-Related Cancer|April 20, 2021

Targeting EML4-ALK gene fusion variant 3 in thyroid cancerMehtap Derya Aydemirli, Jaap D H van Eendenburg, Tom van Wezel, et al.

BMC Cancer|January 21, 2016

(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challengesTatiana C Schneider, Ellen Kapiteijn, Tom van Wezel, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|August 4, 2020

Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapyMaaike Dotinga, Dennis Vriens, Floris van Velden, et al.

Pageof 16

Search research articles

Showing results (11-20 of 158) with videos related to